Literature DB >> 2322651

Role of transforming growth factor-alpha-related peptides in the autocrine/paracrine control of experimental breast cancer growth in vitro by estradiol, prolactin, and progesterone.

A Manni1, C Wright, B Badger, M Bartholomew, M Herlyn, J Mendelsohn, H Masui, L Demers.   

Abstract

We have recently suggested that estradiol (E2), prolactin (oPrl), and progesterone (Pg) support the growth of the hormone-responsive N-nitrosomethylurea (NMU) rat mammary tumor in soft agar through autocrine/paracrine mechanisms. To gain insight into the nature of these hormonally regulated growth factors, we tested the ability of two monoclonal antibodies (MAb-425 and 528) directed against the epidermal growth factor receptor (EGF-R) to inhibit the colony-stimulating effects of conditioned media (CM) obtained from E2, oPrl, and Pg-treated NMU rat mammary tumors. Since both MAbs are specific for human EGF-R, MCF-7 breast cancer cells grown in soft agar in the absence of serum were used as our indicator system. Both MAb-425 and 528 totally abolished the colony-stimulating effect of genuine EGF, while having no agonistic/antagonistic action when added alone. Both MAb-425 and 528 markedly inhibited the colony-stimulating effect of rat mammary tumor E2-CM in a dose-dependent fashion. MAb-425 was also found to inhibit the growth-promoting action of Pg-CM, although this effect appeared to be somewhat less consistent and pronounced than that observed with E2-CM. In contrast, the colony-stimulating effect of Prl-CM was only rarely and, usually, modestly affected by the addition of either MAb-425 or 528. Our data suggest that in the NMU mammary tumor grown in soft agar, EGF/TGF alpha-related peptides are produced upon exposure to E2 and possibly Pg but only rarely following Prl administration. The possible role of these growth factors as mediators of hormonal effects in our experimental system remains to be established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322651     DOI: 10.1007/bf01810779

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  31 in total

1.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines.

Authors:  R B Dickson; S E Bates; M E McManaway; M E Lippman
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.

Authors:  L C Murphy; H Dotzlaw
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

3.  Autocrine stimulation by estradiol-regulated growth factors of rat hormone-responsive mammary cancer: interaction with the polyamine pathway.

Authors:  A Manni; C Wright; P Feil; L Baranao; L Demers; M Garcia; H Rochefort
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  Evaluation of a direct solid-phase radioimmunoassay for progesterone, useful for monitoring luteal function.

Authors:  N P Kubasik; G D Hallauer; R G Brodows
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

Review 5.  Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.

Authors:  M E Lippman; R B Dickson; E P Gelmann; N Rosen; C Knabbe; S Bates; D Bronzert; K Huff; A Kasid
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

6.  Species-specificity of estradiol regulated growth factors in breast cancer.

Authors:  A Manni; B Badger; C Wright; J Glenn; S R Ahmed; L M Demers
Journal:  Eur J Cancer Clin Oncol       Date:  1988-08

7.  Polyamines and the synthesis of estradiol-regulated growth factors in rat mammary cancer in culture.

Authors:  A Manni; C Wright; G D Luk; G Davis; L M Demers
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  Hormonal therapies for breast cancer: can progestogens stimulate growth?

Authors:  H A Braunsberg; N G Coldham; W Wong
Journal:  Cancer Lett       Date:  1986-02       Impact factor: 8.679

9.  Role of polyamines in the synthesis of prolactin-regulated growth factors by experimental breast cancer in culture.

Authors:  A Manni; B Badger; C Wright; S R Ahmed; S J Santner; G Luk
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

10.  Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide.

Authors:  U Murthy; A Basu; U Rodeck; M Herlyn; A H Ross; M Das
Journal:  Arch Biochem Biophys       Date:  1987-02-01       Impact factor: 4.013

View more
  3 in total

1.  Immunolocalization of alpha-transforming growth factor in the developing rat mammary gland in vivo, rat mammary cells in vitro and in human breast diseases.

Authors:  J McAndrew; P S Rudland; A M Platt-Higgins; J A Smith
Journal:  Histochem J       Date:  1994-04

Review 2.  Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Authors:  N Normanno; F Ciardiello; R Brandt; D S Salomon
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

3.  Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar.

Authors:  A Manni; C Wright; H Buck
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.